Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 1 pseudogene 49 (HMGB1P49) is classified as a pseudogene, meaning it is a non-functional copy or fragment of the HMGB1 gene without ability to encode a functional protein[2]. Pseudogenes like HMGB1P49 may sometimes have regulatory RNA functions, but there are no data or publications indicating that HMGB1P49 has any such roles or is involved in disease processes[4]. Therefore, it is not considered a therapeutic target and has no direct biological, disease, or pharmacological relevance. Note: If your interest is in the *functional* protein "High-mobility group box 1" (HMGB1), this is a non-histone chromatin-associated protein with roles in DNA binding, chromatin remodeling, and extracellular signaling in inflammation and cancer[1][3][5]. However, HMGB1P49 itself does **not** have these properties.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 1 pseudogene 49 (HMGB1P49).